Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 661–675 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3318 RPS24 Gene Diamond-Blackfan Anemia Type 3 Genetic Test This test identifies pathogenic variants within the RPS24 gene associated with Diamond-Blackfan anemia type 3.	Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RPS24 gene", "Ribosomal biogenesis impairment"] Parameters [] Preparation ["No specific fasting required", "Patients should not discontinue medication without consulting their treating haematologist"] Indications ["Suspected Diamond-Blackfan anemia type 3", "Family history of Diamond-Blackfan anemia", "Need for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81258-7 ICD-10: D61.0 Clinical summary This test identifies pathogenic variants within the RPS24 gene associated with Diamond-Blackfan anemia type 3.
TEST-3779 RTN3 Gene Alzheimer’s Disease & RTN3-Related Genetic Test This test evaluates the entire coding region of the RTN3 gene for pathogenic variants associated with an increased risk of Alzheimer's disease.	Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RTN3 gene variants", "Copy Number Variations (CNV) in RTN3"] Parameters [] Preparation [] Indications ["Familial risk stratification for Alzheimer's disease", "Early lifestyle interventions", "Personalised monitoring plans"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G30.9, Z13.89 Clinical summary This test evaluates the entire coding region of the RTN3 gene for pathogenic variants associated with an increased risk of Alzheimer's disease.
TEST-2043 RUNX1 Gene Leukemia, Acute Myeloid Genetic Test This test evaluates for mutations within the RUNX1 gene, which are associated with acute myeloid leukemia (AML) and familial platelet disorders.	Peripheral whole blood or Formalin-Fixed Paraffin-Embedded (FFPE) tissue block	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RUNX1 gene mutations (germline and somatic)", "Variant detection (known and novel)"] Parameters [] Preparation ["No fasting required", "No medication changes required", "Inform phlebotomist of all anticoagulants"] Indications ["Diagnosis of AML", "Risk stratification in AML", "Guiding targeted therapy", "Familial risk assessment", "Distinguishing sporadic vs. inherited forms"] Measurement technique Confirm with laboratory Codes LOINC: 81256-4 ICD-10: C92.00, D46.9, Z15.02 Clinical summary This test evaluates for mutations within the RUNX1 gene, which are associated with acute myeloid leukemia (AML) and familial platelet disorders.
TEST-1140 RUNX1-RUNX1T1 (AML1-ETO) t(8;21) Quantitative Test This test quantifies the amount of RUNX1-RUNX1T1 fusion gene transcripts in a blood or bone marrow sample.	Peripheral blood or bone marrow aspirate	3–4 business days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RUNX1-RUNX1T1 fusion gene transcripts", "Minimal Residual Disease (MRD)"] Parameters [] Preparation ["Fasting is not required.", "You can generally take all prescribed medications unless your doctor instructs otherwise.", "For bone marrow aspiration, follow your physician’s specific instructions about blood thinners."] Indications ["Monitoring MRD in AML patients with t(8;21)", "Assessing remission depth", "Detecting early relapse", "Guiding consolidation therapy"] Measurement technique Confirm with laboratory Codes LOINC: 36575-9 ICD-10: C92.00 Clinical summary This test quantifies the amount of RUNX1-RUNX1T1 fusion gene transcripts in a blood or bone marrow sample.
TEST-627 Salmonella Typhi Bacterial Load Test This test detects and quantifies Salmonella Typhi DNA in patient samples to diagnose active typhoid fever.	Peripheral whole blood, stool, or environmental swab	24–36 hours	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Salmonella Typhi DNA", "Bacterial Load Quantification", "Antimicrobial Resistance Profile"] Parameters [] Preparation ["No fasting required", "Avoid antibiotics for 14 days prior unless prescribed", "Bring full clinical history including travel and immunization records"] Indications ["Suspected typhoid fever", "Monitoring treatment response", "Antimicrobial resistance profiling", "Carrier state identification"] Measurement technique Confirm with laboratory Codes LOINC: 50004-7 ICD-10: A01.0 Clinical summary This test detects and quantifies Salmonella Typhi DNA in patient samples to diagnose active typhoid fever.
TEST-3071 Sanger Sequencing (Single Variant) Test This test confirms the presence or absence of a specific, known single nucleotide variant or small insertion/deletion in a gene.	Peripheral Whole Blood	30 Working Days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Specific single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Carrier screening", "Pre-marital genetic counselling", "Paediatric diagnostic workups", "Confirmation of suspected pathogenic variants"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Z13.79 Clinical summary This test confirms the presence or absence of a specific, known single nucleotide variant or small insertion/deletion in a gene.
TEST-1143 Sarcoma Gene Panel Test This test identifies clinically actionable mutations in tumour tissue related to soft tissue and bone cancers (sarcomas). It helps guide targeted therapy, prognosis, and familial r...	Formalin-Fixed Paraffin-Embedded (FFPE) tumour tissue blocks, biopsy slides, or surgical pathology cuts	4–6 weeks	15,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Clinically actionable mutations", "Sarcoma-related genes"] Parameters [] Preparation [] Indications ["Diagnosis of sarcoma", "Targeted therapy selection", "Prognosis assessment", "Familial risk stratification"] Measurement technique Confirm with laboratory Codes LOINC: 104200-6 ICD-10: C49.9 Clinical summary This test identifies clinically actionable mutations in tumour tissue related to soft tissue and bone cancers (sarcomas). It helps guide targeted therapy, prognosis, and familial risk stratification.
TEST-3093 SCA-17 (Spinocerebellar Ataxia) TBP Gene Mutation Test This test detects pathogenic CAG/CAA trinucleotide repeat expansions in the TBP gene associated with Spinocerebellar Ataxia Type 17.	4 mL EDTA Whole Blood (Peripheral Venous)	10–12 Business Days (Express 7 Days Available)	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG/CAA trinucleotide repeat expansions", "TBP gene mutation"] Parameters [{"name": "CAG Repeat Number", "reference_range": " Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting your doctor"] Indications ["Suspected Spinocerebellar Ataxia Type 17", "Family history of SCA-17", "Differential diagnosis of progressive neurodegenerative disorders"] Measurement technique Confirm with laboratory Codes LOINC: 69057-7 ICD-10: G11.2 Clinical summary This test detects pathogenic CAG/CAA trinucleotide repeat expansions in the TBP gene associated with Spinocerebellar Ataxia Type 17.
TEST-3070 SCA2 (Spinocerebellar Ataxia Type 2) Test This diagnostic test evaluates for pathogenic CAG repeat expansions in the ATXN2 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 2 (SCA2).	Peripheral whole blood (EDTA tube)	5 days (sample collected by Tuesday 11 AM → report Saturday)	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansions in the ATXN2 gene", "Pathogenic mutations associated with SCA2"] Parameters [{"name": "CAG Repeat Number", "reference_range": "< 31 repeats (Normal)"}] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting your doctor"] Indications ["Suspected diagnosis of Spinocerebellar Ataxia Type 2", "Family history of SCA2", "Differential diagnosis of hereditary ataxia", "Genetic counseling and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21679-8 ICD-10: G11.2 Clinical summary This diagnostic test evaluates for pathogenic CAG repeat expansions in the ATXN2 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 2 (SCA2).
TEST-4094 SCN2A Gene Test for Benign Familial Infantile Convulsions (BFIC3) This test evaluates the SCN2A gene for pathogenic variants associated with benign familial infantile convulsions type 3 (BFIC3). It uses next-generation sequencing to analyze the e...	Whole Blood (Peripheral) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN2A gene coding region", "SCN2A gene splice sites"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed medications unless advised otherwise by your doctor"] Indications ["Diagnosis of benign familial infantile convulsions type 3 (BFIC3)", "Genetic counseling for families with a history of BFIC3"] Measurement technique Confirm with laboratory Codes LOINC: 74774-9 ICD-10: G40.3 Clinical summary This test evaluates the SCN2A gene for pathogenic variants associated with benign familial infantile convulsions type 3 (BFIC3). It uses next-generation sequencing to analyze the entire coding region and splice sites.
TEST-4190 SCN4B Gene Long QT Syndrome Type 10 Genetic Test This test evaluates the SCN4B gene for pathogenic variants associated with Long QT syndrome type 10.	Peripheral blood (whole blood, extracted DNA, or FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SCN4B gene"] Parameters [] Preparation ["Normalize electrolyte imbalances (potassium, magnesium) before sample collection.", "Avoid sample collection if acute myocardial infarction occurred within the past 30 days."] Indications ["Diagnosis of Long QT syndrome type 10", "Risk stratification for cardiac events", "Family screening for SCN4B-related Long QT syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 92418-9 ICD-10: I45.81 Clinical summary This test evaluates the SCN4B gene for pathogenic variants associated with Long QT syndrome type 10.
TEST-4113 SCN5A Gene (Sick Sinus Syndrome Type 1) Genetic Test This test identifies pathogenic variants in the SCN5A gene associated with Sick Sinus Syndrome Type 1, an inherited cardiac conduction disorder.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in SCN5A gene", "Novel variants in SCN5A gene"] Parameters [] Preparation ["Informed consent required", "Pre-test genetic counseling mandatory"] Indications ["Diagnosis of Sick Sinus Syndrome Type 1", "Family screening for SCN5A mutations", "Athlete clearance", "Suspected inherited sinus node dysfunction", "ECG findings of sinus pauses"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I49.5 Clinical summary This test identifies pathogenic variants in the SCN5A gene associated with Sick Sinus Syndrome Type 1, an inherited cardiac conduction disorder.
TEST-4179 SCN5A Gene Long QT Syndrome Type 3 Genetic Test This test identifies pathogenic variants in the SCN5A gene associated with Long QT Syndrome Type 3 (LQT3).	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SCN5A gene"] Parameters [] Preparation ["Report recent blood transfusion ( Indications ["Suspected Long QT Syndrome Type 3", "Family history of LQT3 or sudden cardiac death", "Risk stratification for cardiac arrhythmias"] Measurement technique Confirm with laboratory Codes LOINC: 83134-6 ICD-10: I45.82 Clinical summary This test identifies pathogenic variants in the SCN5A gene associated with Long QT Syndrome Type 3 (LQT3).
TEST-4441 SCN9A Gene Generalized Epilepsy with Febrile Seizures Plus Type 7 (GEFS+7) Genetic Test This test evaluates the SCN9A gene for pathogenic variants associated with Generalized Epilepsy with Febrile Seizures Plus Type 7 (GEFS+7). It utilizes next-generation sequencing (...	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN9A gene sequence", "Copy-Number Variants (CNVs) in SCN9A"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusions"] Indications ["Suspected diagnosis of GEFS+7", "Family history of GEFS+7", "Need for genetic counseling regarding epilepsy risk"] Measurement technique Confirm with laboratory Codes LOINC: 81326-5 ICD-10: G40.3, G40.8 Clinical summary This test evaluates the SCN9A gene for pathogenic variants associated with Generalized Epilepsy with Febrile Seizures Plus Type 7 (GEFS+7). It utilizes next-generation sequencing (NGS) to detect single-nucleotide variants, small insertions/deletions, and copy-number variants.
TEST-1946 SDHA Gene Paragangliomas Type 5 Genetic Test This test evaluates the SDHA gene for pathogenic variants associated with hereditary paraganglioma-pheochromocytoma syndrome type 5.	Whole Blood, Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SDHA gene coding region", "Copy number variations (CNVs) in SDHA"] Parameters [] Preparation ["A formal genetic counselling session and documented clinical history are mandatory before sample collection."] Indications ["Personal or family history of paragangliomas or pheochromocytomas", "Asymptomatic at-risk relatives of a known mutation carrier", "Screening for hereditary paraganglioma-pheochromocytoma syndrome type 5"] Measurement technique Confirm with laboratory Codes LOINC: 59041-2 ICD-10: D44.6, Z15.0 Clinical summary This test evaluates the SDHA gene for pathogenic variants associated with hereditary paraganglioma-pheochromocytoma syndrome type 5.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories